Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Lossnews2024-12-04T23:10:42+00:00December 4th, 2024|The New York Times|
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stancenews2024-12-04T21:23:56+00:00December 4th, 2024|The New York Times|
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trialsnews2024-10-23T14:19:56+00:00October 23rd, 2024|The New York Times|
Eli Lilly’s Popular Weight Loss Drug, Zepbound, Is Getting a Price Cutnews2024-08-27T10:45:07+00:00August 27th, 2024|The New York Times|
U.S. Unveils Price Limits for 10 Costly or Common Medicationsnews2024-08-15T19:39:11+00:00August 15th, 2024|The New York Times|
U.S. Announces Prices for First Drugs Picked for Medicare Negotiationsnews2024-08-15T16:38:11+00:00August 15th, 2024|The New York Times|
Ozempic y otros medicamentos para adelgazar: ¿Cuál elegir?news2024-07-23T05:30:10+00:00July 23rd, 2024|The New York Times|
Ozempic and Weight Loss Drugs: Which Should You Choose?news2024-07-19T20:59:44+00:00July 19th, 2024|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
Algunos estados en EE. UU. afirman que no pueden costear Ozempic y otros medicamentos para perder pesonews2024-06-29T16:11:41+00:00June 29th, 2024|The New York Times|
